Sino Biopharmaceutical Limited announced that Ms. Li Mingqin has retired as an executive director of the Company at the conclusion of the annual general meeting of the Company held on 5 June 2024 (the "AGM"). Ms. Li did not offer herself for re-election at the AGM as she has reached the retirement age. Ms. Li has also ceased to be a member of the environmental, social and governance committee of the Company and resigned from all positions with the Company and its subsidiaries.

Ms. Li has confirmed that she has no disagreement with the Board and that there is no matter relating to her retirement which needs to be brought to the attention of the shareholders of the Company.